D-Index & Metrics Best Publications
Manuel Sobrinho-Simões

Manuel Sobrinho-Simões

Medicine
Portugal
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 21,963 412 World Ranking 11021 National Ranking 12

Research.com Recognitions

Awards & Achievements

2022 - Research.com Medicine in Portugal Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His scientific interests lie mostly in Pathology, Thyroid, Carcinoma, Thyroid carcinoma and Cancer research. His Pathology research incorporates elements of Stomach and Germline mutation. His biological study spans a wide range of topics, including Differential diagnosis, Adenoma and Vimentin.

The various areas that Manuel Sobrinho-Simões examines in his Carcinoma study include Retrospective cohort study, Cancer, Single-strand conformation polymorphism and Microsatellite instability. Manuel Sobrinho-Simões combines subjects such as Follicular phase, Thyroid cancer and Adenocarcinoma with his study of Thyroid carcinoma. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Gene, Carcinogenesis and Exon.

His most cited work include:

  • BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC (556 citations)
  • Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma (555 citations)
  • Frequency of TERT promoter mutations in human cancers. (550 citations)

What are the main themes of his work throughout his whole career to date?

Pathology, Thyroid, Thyroid carcinoma, Cancer research and Carcinoma are his primary areas of study. As part of one scientific family, Manuel Sobrinho-Simões deals mainly with the area of Pathology, narrowing it down to issues related to the Calcitonin, and often Medullary carcinoma. His studies deal with areas such as Cell and Adenoma as well as Thyroid.

His work in Thyroid carcinoma addresses subjects such as Thyroid cancer, which are connected to disciplines such as Anatomical pathology and Malignancy. He usually deals with Cancer research and limits it to topics linked to Carcinogenesis and Molecular biology. His studies in Carcinoma integrate themes in fields like Cancer, Adenocarcinoma, Thyroid tumors and Microsatellite instability.

He most often published in these fields:

  • Pathology (74.95%)
  • Thyroid (56.26%)
  • Thyroid carcinoma (48.41%)

What were the highlights of his more recent work (between 2012-2021)?

  • Thyroid (56.26%)
  • Pathology (74.95%)
  • Thyroid carcinoma (48.41%)

In recent papers he was focusing on the following fields of study:

His main research concerns Thyroid, Pathology, Thyroid carcinoma, Thyroid cancer and Cancer research. His Thyroid study combines topics from a wide range of disciplines, such as Differential diagnosis and Calcitonin. His study looks at the intersection of Pathology and topics like Cell with Lymphoma and Phenotype.

His Thyroid carcinoma study combines topics in areas such as Cancer, Osteopontin and Follicular phase. His Thyroid cancer study also includes

  • Malignancy which connect with Endocrine system,
  • Biopsy that intertwine with fields like Papillary Thyroid Microcarcinoma and Clinical risk factor. His Cancer research research is multidisciplinary, incorporating perspectives in Carcinogenesis, Tert promoter, Telomerase and Somatic cell.

Between 2012 and 2021, his most popular works were:

  • Frequency of TERT promoter mutations in human cancers. (550 citations)
  • Frequency of TERT promoter mutations in human cancers. (550 citations)
  • TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. (315 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Thyroid carcinoma, Thyroid, Pathology, Thyroid cancer and Internal medicine. His work carried out in the field of Thyroid carcinoma brings together such families of science as Carcinoma, Lymph node and Thyroglobulin. His Thyroid research integrates issues from Carcinogenesis, Cell culture, Melanoma and Mitochondrion.

His work deals with themes such as Cell, Follicular phase, Metastasis and Familial adenomatous polyposis, which intersect with Pathology. Manuel Sobrinho-Simões has researched Thyroid cancer in several fields, including Cancer research, Thyroid nodules and mitochondrial fusion, MFN2, FIS1. Immunohistochemistry and Neuroblastoma RAS viral oncogene homolog is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Frequency of TERT promoter mutations in human cancers.

João Vinagre;Ana Almeida;Ana Almeida;Helena Pópulo;Rui Batista.
Nature Communications (2013)

836 Citations

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

Paula Soares;Vítor Trovisco;Ana Sofia Rocha;Jorge Lima.
Oncogene (2003)

806 Citations

Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma

Céu Figueiredo;José Carlos Machado;Paul Pharoah;Raquel Seruca.
Journal of the National Cancer Institute (2002)

773 Citations

A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma

José Carlos Machado;Céu Figueiredo;Paulo Canedo;Paul Pharoah.
Gastroenterology (2003)

622 Citations

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.

Marco Volante;Paola Collini;Yuri E. Nikiforov;Atsuhiko Sakamoto.
The American Journal of Surgical Pathology (2007)

555 Citations

Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma

Ricardo V Lloyd;Lori A Erickson;Mary B Casey;King Y Lam.
The American Journal of Surgical Pathology (2004)

507 Citations

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Miguel Melo;Miguel Melo;Adriana Gaspar da Rocha;Adriana Gaspar da Rocha;João Vinagre;João Vinagre;Rui Batista.
The Journal of Clinical Endocrinology and Metabolism (2014)

497 Citations

BRAF mutations are associated with some histological types of papillary thyroid carcinoma.

Vítor Trovisco;Inês Vieira de Castro;Paula Soares;Paula Soares;Valdemar Máximo.
The Journal of Pathology (2004)

460 Citations

Intestinal Metaplasia of Human Stomach Displays Distinct Patterns of Mucin (MUC1, MUC2, MUC5AC, and MUC6) Expression

C A Reis;L David;P Correa;F Carneiro.
Cancer Research (1999)

433 Citations

PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma

P. Castro;A. P. Rebocho;R. J. Soares;J. Magalhães.
The Journal of Clinical Endocrinology and Metabolism (2006)

354 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Manuel Sobrinho-Simões

Fátima Carneiro

Fátima Carneiro

University of Porto

Publications: 128

Raquel Seruca

Raquel Seruca

University of Porto

Publications: 109

Yuri E. Nikiforov

Yuri E. Nikiforov

University of Pittsburgh

Publications: 94

Virginia A. LiVolsi

Virginia A. LiVolsi

University of Pennsylvania

Publications: 92

Celso A. Reis

Celso A. Reis

University of Porto

Publications: 86

Sylvia L. Asa

Sylvia L. Asa

University Health Network

Publications: 80

Zubair W. Baloch

Zubair W. Baloch

University of Pennsylvania

Publications: 70

Timothy L. Cover

Timothy L. Cover

Vanderbilt University Medical Center

Publications: 59

Ronald Ghossein

Ronald Ghossein

Memorial Sloan Kettering Cancer Center

Publications: 54

Mauro Papotti

Mauro Papotti

University of Turin

Publications: 49

Akira Miyauchi

Akira Miyauchi

Tokai University

Publications: 45

Fulvio Basolo

Fulvio Basolo

University of Pisa

Publications: 45

Ricardo V. Lloyd

Ricardo V. Lloyd

University of Wisconsin–Madison

Publications: 43

James A. Fagin

James A. Fagin

Memorial Sloan Kettering Cancer Center

Publications: 43

Kurt Werner Schmid

Kurt Werner Schmid

University of Duisburg-Essen

Publications: 43

Richard M. Peek

Richard M. Peek

Vanderbilt University Medical Center

Publications: 41

Trending Scientists

Song Guo

Song Guo

Hong Kong Polytechnic University

Francesco Marcelloni

Francesco Marcelloni

University of Pisa

Maurizio LONGO

Maurizio LONGO

University of Salerno

Zhihong Man

Zhihong Man

Swinburne University of Technology

Marianne Glasius

Marianne Glasius

Aarhus University

Carlos Moreno-Castilla

Carlos Moreno-Castilla

University of Granada

Ana B. Hungría

Ana B. Hungría

University of Cádiz

Richard Martel

Richard Martel

University of Montreal

Josef Nösberger

Josef Nösberger

ETH Zurich

Guillaume Tcherkez

Guillaume Tcherkez

Australian National University

Kenneth Olden

Kenneth Olden

National Institutes of Health

Brant E. Isakson

Brant E. Isakson

University of Virginia

Jason S. McLellan

Jason S. McLellan

The University of Texas at Austin

Martin Evans

Martin Evans

University of Manchester

Joseph S. Coselli

Joseph S. Coselli

Baylor College of Medicine

Matthew Law

Matthew Law

University of New South Wales

Something went wrong. Please try again later.